Likewise, fibrosis and ventricular dilation and dysfunction can be reduced by both selective CaMKIIδ deletion and by blocking CaMKII activation within the first two weeks of TAC and after the onset of inflammatory cell accumulation [105], thus confirming the CaMKII involvement in the maladaptive response during pressure overload [106]. This evidence concerns the gene CAMK2G and persistent truncus arteriosus.